Ensign Peak Advisors’s aTyr Pharma ATYR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | – | Sell |
|
|||||
|
2025
Q3 | $299K | Buy |
|
|||||
|
2025
Q2 | $1.19M | Buy |
|
|||||
|
2023
Q2 | – | Sell |
|
|||||
|
2023
Q1 | $79.6K | Hold |
|
|||||
|
2022
Q4 | $83K | Hold |
|
|||||
|
2022
Q3 | $114K | Hold |
|
|||||
|
2022
Q2 | $107K | Hold |
|
|||||
|
2022
Q1 | $203K | Hold |
|
|||||
|
2021
Q4 | $283K | Hold |
|
|||||
|
2021
Q3 | $344K | Hold |
|
|||||
|
2021
Q2 | $185K | Hold |
|
|||||
|
2021
Q1 | $169K | Hold |
|
|||||
|
2020
Q4 | $147K | Hold |
|
|||||
|
2020
Q3 | $122K | Hold |
|
|||||
|
2020
Q2 | $168K | Hold |
|
|||||
|
2020
Q1 | $106K | Hold |
|
|||||
|
2019
Q4 | $158K | Buy |
|